Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
about
Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS)Review of health-related quality of life data in multiple myeloma patients treated with novel agents.Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.Health related quality of life in patients with multiple myeloma undergoing a double transplantation.The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma.Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of lifeQuality of life assessment in multiple myeloma patients undergoing dose-reduced tandem autologous stem cell transplantationHealth-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care.The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment.What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools.Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma : A prospective randomised study.Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.Psychometric field testing of the HemoLatin-QoL questionnaire.Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia.Psychometric field study of the new haemophilia quality of life questionnaire for adults: the 'Hemofilia-QoL'.Psychometric Evaluation of a Patient-Reported Symptom Index for Nonmuscle Invasive Bladder Cancer: Field Testing Protocol.Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey.Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma.Cost-effectiveness of high-dose chemotherapy in first-line treatment of advanced multiple myeloma.
P2860
Q30641981-0265F9D2-D349-42FC-8923-763E0D6264CFQ30650394-894A274E-1DA5-4686-8645-3DE3775F6F13Q30912145-76087280-71B0-4686-B9E3-1CD6B529A099Q33210966-70AD10E8-7AD5-4C36-BA47-38D0A1DA5789Q33628746-83FB7416-9923-4572-ABE0-15CBC5D9B676Q34485852-692DC894-959D-4F7C-9964-4CB8DB53A2EAQ35640748-B275DEE7-4F08-4CE5-AC50-3E2C756C179FQ35669893-23B80656-2EED-4079-A7C2-DFDD61A416B0Q36031589-FB6DD847-37C8-4134-A611-24D979B09ABAQ36069700-D6924A6D-37D6-4B90-878E-3361ADC77C59Q37737797-375B105D-6BED-4324-B20B-61C543868E3BQ38044063-63202836-8403-4C53-9BF1-29CF1B9F4C6AQ39154846-985A6E4E-F3BE-4B21-97D2-81E6962453EAQ39416134-DDF0C016-8F6F-4006-9711-F0AC1D0193EAQ39535630-50C308A4-610B-4476-8DAD-59F112A211A1Q45876370-3E38B4E4-A704-4550-8704-5D50C7525408Q45887799-60EED154-5DE3-409B-9FB7-6D2EFC28B32DQ47151720-6B27B0D6-2040-460C-ADCE-30EB932DA733Q48402275-46819481-CB2E-40C9-998B-160DDC113F85Q51564235-C886BA65-8847-464D-AA13-9CC3C99C0647Q53479976-AF804DC8-2019-4A4F-8E9A-25B3D7D06B18
P2860
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development of an EORTC questi ...... tudy Group on Quality of Life.
@ast
Development of an EORTC questi ...... tudy Group on Quality of Life.
@en
Development of an EORTC questi ...... tudy Group on Quality of Life.
@nl
type
label
Development of an EORTC questi ...... tudy Group on Quality of Life.
@ast
Development of an EORTC questi ...... tudy Group on Quality of Life.
@en
Development of an EORTC questi ...... tudy Group on Quality of Life.
@nl
prefLabel
Development of an EORTC questi ...... tudy Group on Quality of Life.
@ast
Development of an EORTC questi ...... tudy Group on Quality of Life.
@en
Development of an EORTC questi ...... tudy Group on Quality of Life.
@nl
P2093
P2860
P1476
Development of an EORTC questi ...... tudy Group on Quality of Life.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.1999.01206.X
P407
P577
1999-03-01T00:00:00Z